ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,453Medicare Part D Prescriptions Filled, Including Refills

Rank: 983 out of 3647

$560K Total Retail Price of All Prescriptions

Rank: 904 out of 3647

555 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 6,580 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 401 322 1 1
AMLODIPINE BESYLATE 324 220 2 2
FUROSEMIDE 294 240 3 8
LISINOPRIL 269 213 4 4
OMEPRAZOLE 236 170 5 3
METOPROLOL TARTRATE 236 185 5 7
HYDROCODONE-ACETAMINOPHEN 215 106 S3 7 12
LEVOTHYROXINE SODIUM 191 150 8 5
OXYCODONE HCL 159 73 S2 9 75
WARFARIN SODIUM 154 132 10 15
METFORMIN HCL 151 108 11 6
HYDROCHLOROTHIAZIDE 142 123 12 9
OXYCODONE-ACETAMINOPHEN 141 100 S2 13 91
METHYLPREDNISOLONE 141 101 13 78
AZITHROMYCIN 141 97 13 34
CLOPIDOGREL 128 110 16 26
CYCLOBENZAPRINE HCL 125 80 R 17 98
ZOLPIDEM TARTRATE 115 90 18 14
TRAMADOL HCL 110 73 19 22
CIPROFLOXACIN HCL 109 75 20 53
TAMSULOSIN HCL 104 99 21 28
CITALOPRAM HBR 102 62 22 25
CARISOPRODOL 97 0 R 23 115
GABAPENTIN 97 59 23 17
ATENOLOL 96 71 25 10
NEXIUM 93 52 26 44
OXYCODONE HCL-ACETAMINOPHEN 89 52 S2 27 104
PLAVIX 89 78 27 39
ALENDRONATE SODIUM 86 60 29 23
PANTOPRAZOLE SODIUM 85 54 30 38
METOPROLOL SUCCINATE 84 61 31 18
SPIRONOLACTONE 77 50 32 77
SUCRALFATE 76 37 33 219
RANITIDINE HCL 70 52 34 29
POTASSIUM CHLORIDE 69 63 35 24
GLIPIZIDE 67 55 36 41
ATORVASTATIN CALCIUM 63 45 37 13
ISOSORBIDE MONONITRATE ER 63 59 37 56
PROAIR HFA 61 33 39 62
LEVOFLOXACIN 60 51 40 87
SERTRALINE HCL 58 49 41 27
ADVAIR DISKUS 57 31 42 52
COMBIVENT 56 23 43 170
LOSARTAN POTASSIUM 55 32 44 11
MIRTAZAPINE 53 43 45 63
CARVEDILOL 50 47 46 20
ALLOPURINOL 50 48 46 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.